R ed blood cells (RBCs) can be stored for up to 42 days at 48C before transfusion. As per the US Food and Drug Administration (FDA) criteria for licensure of RBC storage systems, for the majority of blood donors tested, more than 75% of their stored RBCs continue to circulate at 24 hours posttransfusion. 1 However, there can be substantial donor-to-donor variation in RBC storage. Indeed, it has been documented that RBC units from a significant percentage of donors have 24-hour recoveries of less than 75%, and for a small percentage of donors, 24-hour recoveries are very poor (in the range of 20%-30%). 2 The basis for donor-to-donor variability is poorly understood, but there is good evidence that it has a strong genetic component, at least at the metabolic level. [3] [4] [5] [6] [7] Using tractable animal models of RBC storage, we have documented that both hemolysis and decreased 24-hour recoveries vary in genetically distinct strains of inbred mice. 8, 9 These strains serve as a platform to study basic mechanisms of variant RBC storage. We have recently reported that among 13 different strains tested, C57BL/6 (B6) mice have the best 24-hour recoveries whereas FVB donors store poorly. 8 In the current report, we tested the hypothesis that storage biology of a ABBREVIATIONS: G6PD 5 glucose-6-phosphate dehydrogenase; GFP 5 green fluorescent protein. given RBC is affected by the other RBCs in its storage environment. This was carried out by a series of "co-storage" experiments using the B6 and FVB strains. Herein, we report that the storage properties of RBCs from different donor strains are altered by co-storage with RBCs from other strains. This appears to require cell-tocell contact or at least communication via large biologic entities, as the effect is not transferred across semipermeable membranes (0.4-mm cutoff) in transwell experiments. These studies indicate that RBC storage is a property of the population of cells being stored as a cross-talking entity, not a compilation of isolated intrinsic biology of each individual RBC. These findings have mechanistic importance to understanding RBC biology, in the context of both blood storage and normal RBC biology. In addition, these findings may have practical implications with regard to strategies of RBC storage and RBC storage studies, if the findings translate into human RBC storage biology.
MATERIALS AND METHODS

Mice
UbiC-GFP mice (on a B6 background; called GFP.B6 hereafter), C57BL/6J (B6) mice, and FVB/NJ (FVB) mice were each purchased from The Jackson Laboratory. HOD and K1 mice were generated as previously described. 10 The use of this approach normalizes the number of RBCs injected and avoids misinterpreting either in-thetube hemolysis or decreased transfusion volume as decreased 24-hour recoveries. While HOD does represent an alloantigen, the 24-hour window for the recovery studies performed is too short for a primary humoral immune response.
For GFP.B6 transwell experiments using semipermeable membranes, RBCs were collected and stored as previously described 12 and as above. A quantity of 325 mL of GFP.B6 or a mixture of GFP.B6 and B6 (or FVB) RBCs at 75% Hct were added to the bottom-and-top wells of the plate, such that no bubbles were present that might affect free diffusion across membranes. RBCs were stored in Corning transwell polycarbonate membrane cell culture inserts (product code CLS3413), purchased from Sigma. In this system, the wells are separated by a membrane with mean pore size of 0.4 mm. Before storage, RBC mixture levels in bottom wells were checked to ensure that they were touching the semipermeable membrane of the top well, allowing for diffusion across their interface. Plates were stored for 7 days at 48C. After storage, the transwells were disassembled and RBCs from the top-and-bottom chambers were recovered separately, resuspended in 1003 mL of PBS, spiked with 23 mL of fresh HOD tracer RBCs, and transfused into B6 recipients. Ratios of HOD RBCs to stored GFP RBCs were determined in both pretransfusion samples and peripheral blood from recipients 24 hours after transfusion, and the same calculation was carried out as above. For B6 and FVB transwell experiments using semipermeable membranes, RBCs were collected and stored as 
Transwell plate validation
The ability of small molecules to pass across the transwell membrane was tested by depositing anti-K1 (PUMA1) 13 into the top well and K1 RBCs into the bottom well, followed by staining K1 RBCs recovered from bottom well with APC-conjugated goat anti-mouse immunoglobulins (BD Cat. 550826) as above.
Statistical analysis
Statistical analysis was performed using computer software (Graphpad PRISM 6, GraphPad, Inc.) as follows: For GFP.B6 and GFP.F1 co-storage experiments, each replicate experiment was analyzed using means and standard deviations (SDs), and treatment conditions were compared by two-way analysis of variance (ANOVA) with Bonferroni post hoc analysis (for GFP.B6) and one-way ANOVA with Bonferroni post hoc analysis (for GFP.F1); reported p values are corrected for multiple comparisons. To statistically analyze data across the three replicate experiments, fixedeffect meta-analysis was performed with the Web-based "Meta-light" (http://eppi.ioe.ac.uk/free-tools/meta-analysis/). Meta data are presented as mean differences 6 95% confidence intervals (CIs).
For transwell co-storage experiments, each replicate experiment was analyzed using means and SDs and then normalized to the mean value for the first treatment group presented (Fig. 3D ) or left nonnormalized (Fig. 4C) . Values from each experiment were then averaged, and one-way ANOVA with Bonferroni post hoc analysis used to identify (Fig. 1B) . Wildtype FVB or B6 RBCs were co-stored with the test GFP.B6 RBCs at a ratio of 1:1, 1:2, or 1:11, such that the effect of titrating out the amount of "bad-storing" RBCs added to the mixture could be assessed. In all cases, the total RBC storage volume was held constant (Fig. 1C) . GFP.B6 RBCs stored with control B6 RBCs had 24-hour recoveries of more than 80%, consistent with previous reports that B6 RBCs store well (Fig. 1D) . In contrast, 24-hour recoveries of GFP.B6 RBCs were significantly decreased as a result of co-storage with FVB RBCs. This decrease was observed in a dose-dependent fashion. Costorage with FVB RBCs resulted in a decrease in 24-hour recoveries with a mean difference (695% CIs) of 4.1 (62.9)% at the 1:11 ratio, a mean difference of 25.8 (62.2)% at the 1:2 ratio, and a mean difference of 50.5 (63.8)% at the 1:1 ratio. This was not an artifact associated with the mechanical addition of the FVB RBCs to the GFP.B6 RBCs, since wild-type B6 RBCs were added in the same fashion and at the same ratios to GFP.B6 RBCs. These data demonstrate that when co-stored, poorly storing RBCs can transfer their storage properties to RBCs that otherwise store well.
Storage effects are transferred bidirectionally between RBCs that store well and those that store poorly Because GFP transgenic mice are not available on a genetic background with RBCs known to store poorly (e.g., FVB or other strains 8 ) the inverse of the experiment shown in Fig. 1 Fig. 2A for a schematic of experiment). As a control for manipulations and volumes, GFP.F1 RBCs were also stored with B6xFVB F1 RBCs that had no GFP. All stored RBCs were transfused into B6 recipients.
For the representative experiment shown in 
Transfer of RBC storage biology does not occur across a semipermeable membrane
To better characterize the nature by which RBCs affect each other during storage, transwell experiments were carried out using a semipermeable membrane with 0.4-mm pores, thereby preventing cell-to-cell contact of intact RBCs but allowing the free exchange of smaller microparticles and molecules (Figs. 3A and 3B ). The ability of small molecules to cross the membrane was confirmed by adding anti-K1 to the top well and K11 RBCs (K1-GFP) to the bottom well. Staining with anti-IgG demonstrated that anti-K1 IgG had passed through the membrane and bound to RBCs in the bottom chamber (Fig. 3C) .
Four separate transwell storage conditions were carried out (Fig. 3D, bars paired by color) . In each case, both the top well and the bottom well were transfused into B6 recipients, and 24-hour recoveries were determined as above. Two separate conditions were set up as controls. In the first, GFP.B6 RBCs were stored in the top well and GFP.B6 1 B6 RBCs were stored in the bottom well. The second was the inverse, with GFP.B6 1 B6 RBCs in the top well and GFP.B6 in the bottom well. Close to 100% 24-hour recoveries were observed after transfusion of the top well or the bottom well, for either condition. These controls demonstrate that storage does not vary significantly as a result of being in the top well or bottom well of the transwell system. The other two conditions were such that GFP.B6 was in one well, while the other well had GFP.B6 and FVB RBCs stored together. In one case the GFP.B6 was in the top chamber with GFP.B6 1 FVB in the bottom chamber, the other case was the opposite. In both cases, GFP.B6 stored alone had recoveries comparable to the control GFP.B6 whereas GFP.B6 stored with FVB RBCs had poor 24-hour recoveries. Together, these findings indicate that whatever is responsible for transferring storage phenotype does not transmit across a membrane with a 0.4-mm size limit. The lack of transmission across wells was not due to the biology generated from the poorly storing RBCs not being present, as the effect of FVB RBCs upon GFP.B6 RBCs was observed in the communicating well.
One potential caveat to the interpretation of the transwell experiments is that the poor storage phenotype may have failed to transmit across the membrane because it was consumed by the B6 RBCs co-stored with the FVB RBCs. Likewise, the above experimental design does not address the transfer of substances improving RBC storage. To further address these issues, B6 RBCs and FVB RBCs were stored in the top or bottom wells (Fig. 4A) . To allow visualization of the non-GFP RBCs, GFP.F1 recipients were used for poststorage RBC recoveries (Fig. 4A ). An example of the flow cytometry allowing such enumeration is shown (Fig. 4B) . B6 or FVB RBCs were stored in top or bottom wells in the different conditions indicated (Fig. 4C) . There was no difference in B6 RBC 24-hour recoveries, after storage with FVB RBCs versus B6 RBCs in the transwell system; in both cases the B6 RBCs had close to 90% 24-hour recoveries (Fig. 4C) . This was not because FVB RBCs did not store poorly in the transwell system, as FVB 24-hour recoveries were approximately 35%. The same trend was observed regardless of whether B6 or FVB RBCs were stored in the top versus the bottom well. However, storage in the bottom well was worse for either population, as demonstrated by lower 24-hour recoveries from bottom well populations when RBCs from the same donor strain were stored in both top and bottom wells.
DISCUSSION
The current findings presented herein indicate a communication between RBCs that are stored together in the same vessel, such that RBCs that store poorly decrease quality of RBCs that would otherwise have stored well and those that store well "rescue" the storage of those that would otherwise store poorly. This communication does not occur when particles larger than 0.4 mm are prevented from crossing between populations, suggesting that small molecules are not sufficient for the effect and suggesting that direct cell-cell contact may be required. However, we cannot rule out that small molecules may be responsible, but that they are too labile to survive long enough to diffuse across the membrane.
The mechanism of the observed communication is unclear. Metabolomics analysis of multiple strains (including B6 and FVB) have shown that lipid metabolism and degradation (most notably lipid oxidation) emerged as the strongest correlate with poor 24-hour recoveries. 8, 14 Strains that stored better not only had less lipid oxidation but also higher levels of antioxidants and antioxidant pathways involved in prevention and reversal of lipid oxidation (e.g., glutathione and tocopherol [vitamin E]). 8 Thus, it is possible that lipid peroxidation chain reactions transfer from oxidized RBCs to unoxidized RBCs; however, there are no data to support or refute this possibility. Moreover, lipid peroxidation would not give an obvious explanation to how B6 RBCs improve storage of FVB RBCs, unless antioxidant pathways somehow quenched peroxidation chain reactions. Microparticles are also known to accumulate during the storage of murine RBCs, as they do with humans, and fewer microparticles correlate with better storage. 15 As microparticles can have a wide range of sizes, which may or may not traverse the transwell membrane used, future studies may include such investigations. In any case, follow-up studies will clearly be required to elucidate greater detail regarding the mechanism of the observed phenomenon. Nevertheless, the This may occur in healthy humans, but also in disease states where RBC metabolism and senescence is likely altered (e.g., diabetes, sickle cell disease, glucose-6-phosphate dehydrogenase [G6PD] deficiency). G6PD deficiency is a special case. Due to X chromosome inactivation, approximately 50% of mature erythrocytes that leave the bone marrow are normal and 50% are G6PD deficient in females who are heterozygous for G6PD deficiency. 16 Accordingly, they will have distinct populations of RBCs circulating, which may affect each other. Paroxysmal nocturnal hemoglobinuria is a similar situation, although the defect is around GPI-anchored proteins, the defect is on one population of RBCs with other RBCs being normal in the same patient. 17 Thus, the current studies raise the possibility that a cross-talk among qualitatively distinct RBCs in a given individual's circulation may affect general RBC biology. Currently, RBCs are stored only as single-donor units, and there is no mixture of RBCs from different donors during storage. However, in recognition of donor-to-donor differences in RBC storage, it has been suggested that donor RBCs might be pooled before storage, so as to average out the storage effects. 18 Similarly, research on new human RBC storage systems may employ a "pool-andsplit" strategy, by which donor RBCs are pooled and then split into different storage conditions, so as to decrease the likelihood that one donor's particular biology will skew results. The current studies raise the possibility that these approaches may not only average out RBC units by differential storage of different RBCs in the same bag, but may also do so through altering the biology of the whole RBC population. This distinction may be of considerable importance in considering the biology of the RBC storage. However, as the current studies are restricted to a murine model, such speculation depends upon a similar biology occurring in humans, which is as of yet untested. In summary, the data contained herein directly challenge the notion that biology of RBC storage is exclusively intrinsic to the RBC and that the RBCs that make up a stored unit are a population of individual events simply undergoing changes in the presence of each other. In contrast, the data contained herein indicate that RBCs function as a population, with individual RBCs affecting each other. In other words, stored RBCs behave as a multicellular organism and not as a population of isolated intrinsic events. Determination of whether these findings extend to RBC storage biology in other species and/or to in vivo RBC biology outside of the context of RBC storage will require ongoing study.
